NCT01573767 - Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children | Biotech Hunter

Enrollment

463

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Asthma

Interventions

DRUG

Fluticasone propionate 100mcg

all subjects recieve open-label Flovent twice daily duirng the run in and treatment period

DRUG

Placebo

Placebo inhalation powder during treatment period

DRUG

Vilanterol

subjects will recieve 4 weeks via NDPI during treament period

Trial Locations (120)

1000

GSK Investigational Site, Manila

1100

GSK Investigational Site, Quezon City

1113

GSK Investigational Site, Quezon City

1501

GSK Investigational Site, Middelburg

1886

GSK Investigational Site, Berazategui

1888

GSK Investigational Site, San Juan Bautista

1900

GSK Investigational Site, La Plata

4000

GSK Investigational Site, San Miguel de Tucumán

6000

GSK Investigational Site, Cebu City

7500

GSK Investigational Site, Panorama

7600

GSK Investigational Site, Mar del Plata

7764

GSK Investigational Site, CapeTown

10785

GSK Investigational Site, Berlin

15241

GSK Investigational Site, Pittsburgh

21162

GSK Investigational Site, White Marsh

21502

GSK Investigational Site, Geesthacht

22415

GSK Investigational Site, Hamburg

27607

GSK Investigational Site, Raleigh

29118

GSK Investigational Site, Orangeburg

29406

GSK Investigational Site, Charleston

31406

GSK Investigational Site, Savannah

31904

GSK Investigational Site, Columbus

33173

GSK Investigational Site, Miami

33180

GSK Investigational Site, Aventura

33613

GSK Investigational Site, Tampa

34225

GSK Investigational Site, Baunatal-Grossenritte

35209

GSK Investigational Site, Birmingham

36608

GSK Investigational Site, Mobile

38302

GSK Investigational Site, Wolfenbüttel

40356

GSK Investigational Site, Nicholasville

44791

GSK Investigational Site, Bochum

45040

GSK Investigational Site, Zapopan

45231

GSK Investigational Site, Cincinnati

45414

GSK Investigational Site, Dayton

46483

GSK Investigational Site, Wesel

47533

GSK Investigational Site, Kleve-Materborn

56068

GSK Investigational Site, Koblenz

59063

GSK Investigational Site, Hamm

60596

GSK Investigational Site, Frankfurt am Main

61093

GSK Investigational Site, Kharkiv

61761

GSK Investigational Site, Normal

62269

GSK Investigational Site, Shiloh

63263

GSK Investigational Site, Neu-Isenburg

65203

GSK Investigational Site, Columbia

66215

GSK Investigational Site, Lenexa

68107

GSK Investigational Site, Omaha

68163

GSK Investigational Site, Mannheim

69063

GSK Investigational Site, Zaporizhia

69076

GSK Investigational Site, Zaporizhia

72000

GSK Investigational Site, Puebla, Pue

72205

GSK Investigational Site, Little Rock

73112

GSK Investigational Site, Oklahoma City

75230

GSK Investigational Site, Dallas

76712

GSK Investigational Site, Waco

77379

GSK Investigational Site, Spring

78750

GSK Investigational Site, Austin

83026

GSK Investigational Site, Rosenheim

86100

GSK Investigational Site, Villahermosa

90274

GSK Investigational Site, Rolling Hills Estates

90808

GSK Investigational Site, Long Beach

92647

GSK Investigational Site, Huntington Beach

92663

GSK Investigational Site, Newport Beach

92691

GSK Investigational Site, Mission Viejo

92868

GSK Investigational Site, Orange

97504

GSK Investigational Site, Medford

98724

GSK Investigational Site, Neuhaus am Rennweg

2520594

GSK Investigational Site, Viña del Mar

7520349

GSK Investigational Site, Santiago

8207257

GSK Investigational Site, Puente Alto - Santiago

8380453

GSK Investigational Site, Santiago

05403

GSK Investigational Site, South Burlington

C1431FWO

GSK Investigational Site, Ciudad de Buenos Aires

B6500BWQ

GSK Investigational Site, Nueve de Julio

M5500CCG

GSK Investigational Site, Mendoza

A4400ERH

GSK Investigational Site, Salta

S2000DBS

GSK Investigational Site, Rosario

S2000JKR

GSK Investigational Site, Rosario

C1121ABE

GSK Investigational Site, Buenos Aires

C1425BEN

GSK Investigational Site, Buenos Aires

S2000BRH

GSK Investigational Site, Rosario

0119

GSK Investigational Site, Tbilisi

0159

GSK Investigational Site, Tbilisi

0160

GSK Investigational Site, Tbilisi

0186

GSK Investigational Site, Tbilisi

01307

GSK Investigational Site, Dresden

04178

GSK Investigational Site, Leipzig

260-0001

GSK Investigational Site, Chiba

273-0035

GSK Investigational Site, Chiba

811-1394

GSK Investigational Site, Fukuoka

720-8520

GSK Investigational Site, Hiroshima

006-0831

GSK Investigational Site, Hokkaido

064-0821

GSK Investigational Site, Hokkaido

653-0021

GSK Investigational Site, Hyōgo

762-0031

GSK Investigational Site, Kagawa

154-0017

GSK Investigational Site, Tokyo

157-0066

GSK Investigational Site, Tokyo

158-0097

GSK Investigational Site, Tokyo

646-8558

GSK Investigational Site, Wakayama

04530

GSK Investigational Site, Mexico City

Lima 1

GSK Investigational Site, Lima

Lima 27

GSK Investigational Site, Lima

Lima 32

GSK Investigational Site, San Miguel

Lima 33

GSK Investigational Site, Santiago de Surco

34-212

GSK Investigational Site, Bieńkówka

85-096

GSK Investigational Site, Bydgoszcz

31-159

GSK Investigational Site, Krakow

20-093

GSK Investigational Site, Lublin

56-400

GSK Investigational Site, Oleśnica

63-400

GSK Investigational Site, Ostrów Wielkopolski

41-103

GSK Investigational Site, Siemianowice Śląskie

50-445

GSK Investigational Site, Wroclaw

51-511

GSK Investigational Site, Wroclaw

47-120

GSK Investigational Site, Zawadzkie

00917

GSK Investigational Site, Hato Rey

826 05

GSK Investigational Site, Bratislava

036 59

GSK Investigational Site, Martin

059 81

GSK Investigational Site, Vysoké Tatry

0184

GSK Investigational Site, Meyerspark

03680

GSK Investigational Site, Kyiv

04050

GSK Investigational Site, Kyiv